CAMBRIDGE, Mass. , May 31, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy , President and Chief Executive Officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference on Tuesday, June 5, 2012 at 11:00 a.m.
Data on the safety and initial activity of MM-121 combined with erlotinib to be presented MM-111 multi-arm combination and MM-302 monotherapy Phase 1 designs to be presented CAMBRIDGE, Mass. , May 30, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc.
CAMBRIDGE, Mass. , May 10, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK) today announced that Robert Mulroy , President and Chief Executive Officer, is scheduled to present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16, 2012 at 8:00
CAMBRIDGE, Mass. , March 28, 2012 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer, today